首页> 外文期刊>The annals of pharmacotherapy >Delivery of optimized inpatient anticoagulation therapy: Consensus statement from the anticoagulation forum [Terapia de anticoagulación optimizada en el paciente hospitalizado: Declaración de consenso del Foro de Anticoagulación]
【24h】

Delivery of optimized inpatient anticoagulation therapy: Consensus statement from the anticoagulation forum [Terapia de anticoagulación optimizada en el paciente hospitalizado: Declaración de consenso del Foro de Anticoagulación]

机译:提供最佳的住院抗凝治疗:抗凝论坛的共识声明[住院患者的最佳抗凝治疗:抗凝论坛的共识声明]

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To provide recommendations for optimized anticoagulant therapy in the inpatient setting and outline broad elements that need to be in place for effective management of anticoagulant therapy in hospitalized patients; the guidelines are designed to promote optimization of patient clinical outcomes while minimizing the risks for potential anticoagulation-related errors and adverse events. Data Sources: The medical literature was reviewed using MEDLINE (1946-January 2013), EMBASE (1980-January 2013), and PubMed (1947-January 2013) for topics and key words including, but not limited to, standards of practice, national guidelines, patient safety initiatives, and regulatory requirements pertaining to anticoagulant use in the inpatient setting. Non-English-language publications were excluded. Specific MeSH terms used include algorithms, anticoagulants/administration and dosage/adverse effects/therapeutic use, clinical protocols/standards, decision support systems, drug monitoring/methods, humans, inpatients, efficiency/ organizational, outcome and process assessment (health care), patient care team/organization and administration, program development/standards, quality improvement/organization and administration, thrombosis/ drug therapy, thrombosis/prevention and control, risk assessment/standards, patient safety/standards, and risk management/methods. Study Selection and Data Extraction: Because of this document's scope, the medical literature was searched using a variety of strategies. When possible, recommendations are supported by available evidence; however, because this paper deals with processes and systems of care, high-quality evidence (eg, controlled trials) is unavailable. In these cases, recommendations represent the consensus opinion of all authors and are endorsed by the Board of Directors of the Anticoagulation Forum, an organization dedicated to optimizing anticoagulation care. The board is composed of physicians, pharmacists, and nurses with demonstrated expertise and experience in the management of patients receiving anticoagulation therapy. Data Synthesis: Recommendations for delivering optimized inpatient anticoagulation therapy were developed collaboratively by the authors and are summarized in 8 key areas: (1) process, (2) accountability, (3) integration, (4) standards of practice, (5) provider education and competency, (6) patient education, (7) care transitions, and (8) outcomes. Recommendations are intended to inform the development of coordinated care systems containing elements with demonstrated benefit in improvement of anticoagulation therapy outcomes. Recommendations for delivering optimized inpatient anticoagulation therapy are intended to apply to all clinicians involved in the care of hospitalized patients receiving anticoagulation therapy. Conclusions: Anticoagulants are high-risk medications associated with a significant rate of medication errors among hospitalized patients. Several national organizations have introduced initiatives to reduce the likelihood of patient harm associated with the use of anticoagulants. Health care organizations are under increasing pressure to develop systems to ensure the safe and effective use of anticoagulants in the inpatient setting. This document provides consensus guidelines for anticoagulant therapy in the inpatient setting and serves as a companion document to prior guidelines relevant for outpatients.
机译:目的:为住院患者的最佳抗凝治疗提供建议,并概述在住院患者中有效管理抗凝治疗所需的广泛要素;该指南旨在促进患者临床结局的优化,同时将与抗凝相关的潜在错误和不良事件的风险降至最低。数据来源:医学文献使用MEDLINE(1946-January),EMBASE(1980-January 2013)和PubMed(1947-January 2013)进行了主题和关键词的审查,包括但不限于实践标准,国家有关在住院环境中使用抗凝剂的指南,患者安全措施和法规要求。非英语出版物被排除在外。所使用的特定MeSH术语包括算法,抗凝剂/给药和剂量/不良作用/治疗用途,临床方案/标准,决策支持系统,药物监测/方法,人,住院病人,效率/组织,结果和过程评估(卫生保健),病人护理团队/组织和管理,计划制定/标准,质量改进/组织和管理,血栓形成/药物治疗,血栓形成/预防和控制,风险评估/标准,患者安全/标准以及风险管理/方法。研究选择和数据提取:由于本文的范围,因此使用多种策略搜索了医学文献。在可能的情况下,建议应得到可用证据的支持;但是,由于本文涉及护理的过程和系统,因此无法提供高质量的证据(例如,对照试验)。在这些情况下,建议代表所有作者的共识,并得到抗凝论坛理事会(致力于优化抗凝治疗的组织)的认可。该委员会由医师,药剂师和护士组成,他们在接受抗凝治疗的患者管理方面具有公认的专业知识和经验。数据综合:作者共同制定了提供最佳住院抗凝治疗的建议,并总结了8个关键领域:(1)流程,(2)问责制,(3)整合,(4)实践标准,(5)提供者教育和能力,(6)患者教育,(7)过渡护理和(8)结果。这些建议旨在为协调医疗系统的发展提供信息,这些系统包含在改善抗凝治疗效果方面已证明具有优势的要素。提供最佳住院抗凝治疗的建议旨在适用于所有参与接受抗凝治疗的住院患者护理的临床医生。结论:抗凝剂是高危药物,在住院患者中药物错误率很高。几个国家组织已经提出了减少使用抗凝剂对患者造成伤害的可能性的倡议。卫生保健组织承受着越来越大的压力来开发系统,以确保在住院环境中安全有效地使用抗凝剂。该文件提供了住院环境中抗凝治疗的共识性指南,并作为与门诊患者相关的先前指南的配套文件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号